Abstract:BACKGROUND: Apart from haematopoietic stem cell transplantation for haematological disorders many stem cell-based therapies are experimental. However, with only 12 years between human embryonic stem cell isolation and the first clinical trial, development of stem cell products for regenerative medicine has been rapid and numerous clinical trials have begun to investigate their therapeutic potential.SOURCE OF DATA: This review summarizes key clinical trial data, current and future perspectives on stem cell-based products undergoing clinical trials, based on literature search and author research.AREAS OF AGREEMENT: It is widely recognized that the ability to stimulate stem cell differentiation into specialized cells for use as cellular therapies will revolutionize health care and offer major hope for numerous diseases for which there are limited or no therapeutic options.AREAS OF CONTROVERSY: Stem cell-based products are unique and cover a large range of disorders to be treated; therefore, there is significant potential for variation in cell source, type, processing manipulation, the bioprocessing approach and scalability, the cost and purity of manufacture, final product quality and mode of action. As such there are gaps in regulatory and manufacturing frameworks and technologies, only a small number of products are currently within late phase clinical trials and few products have achieved commercialization.GROWING POINTS: Recent developments are encouraging acceleration through the difficulties encountered en route to clinical trials and commercialization of stem cell therapies.AREAS TIMELY FOR DEVELOPING RESEARCH: The field is growing year on year with the first clinical trial using induced pluripotent stem cells anticipated by end 2013.

Clinical translation of pluripotent stem cell-based therapies: successes and challenges

Clinical Translation of Pluripotent Stem Cell Therapies: Challenges and Considerations

Pluripotent Stem Cells in Clinical Setting—New Developments and Overview of Current Status

Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies

Translating stem cell research into development of cellular drugs—a perspective from manufacture of stem cell products and CMC considerations

Challenges to the Clinical Application of Pluripotent Stem Cells: Towards Genomic and Functional Stability.

Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells

Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges

Cell-based therapy technology classifications and translational challenges

Differentiation of human pluripotent stem cells into β-cells: Potential and challenges

Stem Cell Therapy: From Idea to Clinical Practice

Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application

Stem cell-based therapies for retinal diseases: focus on clinical trials and future prospects

Differentiation of pluripotent stem cells for regenerative medicine

Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications

Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation

Stem Cell Therapy and Immunological Rejection in Animal Models

Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes

Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective

Specific Blood Cells Derived From Pluripotent Stem Cells: An Emerging Field With Great Potential In Clinical Cell Therapy

Stem Cell Therapies in Clinical Trials: Progress and Challenges